SCHEMBL12257546

SCHEMBL12257546

CCOC(=O)C1(NC(=O)Cc2c(C)cc(Cl)cc2C)CCC2(CCCO2)CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 2/20 0.32
ABCB11 O95342 1/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
P2RX7 Q99572 8/20 0.32
GABRA1 P14867 1/20 0.31
PLAU P00749 1/20 0.31
PLAT P00750 1/20 0.31
OPRM1 P35372 2/20 0.31
OPRD1 P41143 2/20 0.31
ALDH1A1 P00352 2/20 0.31
OPRK1 P41145 1/20 0.31
SHMT1 P34896 1/20 0.31
SHMT2 P34897 1/20 0.31
PMP22 Q01453 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12382100 0.89 MEN1 (0.34) MEN1KMT2AMAPTABCB11LMNA
SCHEMBL20021197 0.86 P2RX7 (0.33) MEN1KMT2AMAPTABCB11P2RX7
SCHEMBL21082998 0.81 HPGD (0.34) MAPTP2RX7ALDH1A1SHMT1SHMT2
SCHEMBL21128298 0.80 MAPT (0.34) MAPTLMNAP2RX7ALDH1A1SHMT1
SCHEMBL22954436 0.80 MAPT (0.32) KMT2AMAPTLMNAP2RX7ALDH1A1
SCHEMBL21082986 0.79 HPGD (0.33) MAPTP2RX7ALDH1A1TSHR
SCHEMBL21128193 0.79 HPGD (0.33) MAPTP2RX7ALDH1A1TSHR
SCHEMBL21082993 0.78 MAPT (0.32) MAPTLMNAP2RX7ALDH1A1SHMT1
SCHEMBL12738955 0.78 ANO1 (0.37) MAPTLMNAP2RX7ALDH1A1SHMT1
SCHEMBL1153521 0.77 LPAR1 (0.36) MEN1KMT2AMAPTPLAUPLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2185563-B1 OXASPIROCYCLIC SPIRO-SUBSTITUTED TETRAMIC AND TETRONIC ACID DERIVATIVES BAYER IP GMBH (DE) 2015-08-19 EP disclosed
US-8859466-B2 Oxaspirocyclic spiro-substituted tetramic acid and tetronic acid derivatives BAYER CROPSCIENCE AG (DE) 2014-10-14 US disclosed
US-20110263424-A1 Oxaspirocyclic Spiro-Substituted Tetramic Acid and Tetronic Acid Derivatives BAYER CROPSCIENCE AG (DE) 2011-10-27 US disclosed
WO-2009015801-A1 OXASPIROCYCLIC SPIRO-SUBSTITUTED TETRAMIC AND TETRONIC ACID DERIVATIVES BAYER CROPSCIENCE AG (DE) 2009-02-05 WO disclosed
EP-2020413-A1 Oxaspirocyclical spiro-substituted tetram and tetron acid derivatives Bayer CropScience AG (DE) 2009-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263424-A1 Oxaspirocyclic Spiro-Substituted Tetramic Acid and Tetronic Acid Derivatives TBCA, POF1B, DDT MEN1 3983/4885KMT2A 4063/4885MAPT 3987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.